Testing effectiveness (Phase 2)Study completedNCT01513278
What this trial is testing
Study of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer
Who this might be right for
Radiation Induced Dermatitis
Apeiron Biologics 20